01 10Herceptin
02 4Kanjinti
03 3Ontruzant
04 3Phesgo
05 3Trazimera
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 567
2019 Revenue in Millions : 226
Growth (%) : 151
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 6,220
2018 Revenue in Millions : 7,191
Growth (%) : -14
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 572
2020 Revenue in Millions : 567
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 4,158
2019 Revenue in Millions : 6,729
Growth (%) : -38
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,899
2020 Revenue in Millions : 3,956
Growth (%) : -28
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 197
2020 Revenue in Millions : 98
Growth (%) : 101
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 366
2020 Revenue in Millions : 24
Growth (%) : 1,378
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 126
2020 Revenue in Millions : 115
Growth (%) : 10
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 122
2021 Revenue in Millions : 126
Growth (%) : -3
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 316
2021 Revenue in Millions : 572
Growth (%) : -45
LOOKING FOR A SUPPLIER?
